Pharma

Premier

Anton Pavlov recently turned 18 years old. He has entered adulthood, and he already has a favorite thing — he writes his own music and raps. But his life is overshadowed by a rare genetic disease — myodystrophy. This is a progressive weakening of the muscles, leading to a fatal outcome. Anton is in vital need of an expensive and rare medicine, but due to bureaucratic obstacles, he has lost access to it.